These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 3755882
1. [Preoperative systemic chemotherapy (FAC) in 3 cases of advanced breast cancer]. Mizumoto K, Ohyabu H, Ryu S, Jimi M, Ishikawa H, Akashi Y, Miyoshi A, Mawatari Y. Gan To Kagaku Ryoho; 1986 Sep; 13(9):2864-6. PubMed ID: 3755882 [Abstract] [Full Text] [Related]
2. [A case of inflammatory breast cancer treated with preoperative intra-arterial infusion chemotherapy]. Migita T, Shiiba K, Saito Y, Shibata C, Matsuno S. Gan To Kagaku Ryoho; 1994 Dec; 21(16):2825-8. PubMed ID: 7993122 [Abstract] [Full Text] [Related]
6. [Two cases of advanced breast cancer effectively treated with chemoendocrine therapy and radiotherapy]. Kimura M, Hagiwara S, Hirose K, Shimokawa Y, Iwai K, Uemura K. Gan To Kagaku Ryoho; 1994 Oct; 21(14):2505-8. PubMed ID: 7944499 [Abstract] [Full Text] [Related]
7. [Effects of neoadjuvant intra-arterial infusion chemotherapy in patients with stage III breast carcinoma]. Higuchi K, Onda M, Furukawa K, Minobe K, Tanaka N, Arima Y, Hasegawa H. Gan To Kagaku Ryoho; 1997 Sep; 24(12):1799-802. PubMed ID: 9382536 [Abstract] [Full Text] [Related]
8. [Recurrence of right breast cancer at the thoracic wall successfully treated with intra-arterial infusion of doxorubicin hydrochloride--a case report]. Hasegawa S, Yamamoto Y, Ishiwa N, Yoshikawa T, Morinaga S, Noguchi Y, Matsumoto A, Nishimura J, Okoshi T. Gan To Kagaku Ryoho; 2002 Nov; 29(12):2399-401. PubMed ID: 12484084 [Abstract] [Full Text] [Related]
9. A comparison of the outcomes of non-randomised chemotherapy regimens in node positive breast cancer. Kuru B, Camlibel M, Dinc S, Gulcelik MA, Atalay C, Alagol H. J Exp Clin Cancer Res; 2005 Sep; 24(3):363-72. PubMed ID: 16270522 [Abstract] [Full Text] [Related]
10. [Preoperative intensive chemotherapy of operable breast cancer]. Zhang B. Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):228-30. PubMed ID: 2558871 [Abstract] [Full Text] [Related]
14. Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks. Green MC, Buzdar AU, Smith T, Ibrahim NK, Valero V, Rosales MF, Cristofanilli M, Booser DJ, Pusztai L, Rivera E, Theriault RL, Carter C, Frye D, Hunt KK, Symmans WF, Strom EA, Sahin AA, Sikov W, Hortobagyi GN. J Clin Oncol; 2005 Sep 01; 23(25):5983-92. PubMed ID: 16087943 [Abstract] [Full Text] [Related]
15. Prospective randomized trial of paclitaxel alone versus 5-fluorouracil/doxorubicin/cyclophosphamide as induction therapy in patients with operable breast cancer. Buzdar AU, Hortobagyi GN, Asmar L, Theriault RL, Rahman Z, McNeese M, Singletary S, Ames F. Semin Oncol; 1997 Oct 01; 24(5 Suppl 17):S17-31-S17-34. PubMed ID: 9374089 [Abstract] [Full Text] [Related]
16. [High-dose chemotherapy rescued with peripheral blood stem cell transplantation for high-risk patients with breast cancer]. Kim S, Shiba E, Taguchi T, Kimoto Y, Inoue T, Shimazu K, Takamura Y, Tanji Y, Izukura M, Ogawa H, Sugiyama H, Kubota T, Kimura T, Takai S. Gan To Kagaku Ryoho; 1996 Apr 01; 23(5):635-8. PubMed ID: 8678525 [No Abstract] [Full Text] [Related]